PMID- 24067471 OWN - NLM STAT- MEDLINE DCOM- 20140328 LR - 20221207 IS - 0394-6320 (Print) IS - 0394-6320 (Linking) VI - 26 IP - 3 DP - 2013 Jul-Sep TI - Association of HLA-DQB1*0501 with scleroderma and its clinical features in Chinese population. PG - 747-51 AB - Specific human leukocyte antigen (HLA) DQB1 alleles confer strong susceptibility to systemic sclerosis (SSc). However, the frequencies of specific DQB1 alleles and their associations with SSc vary according to ethnicity and clinical features of SSc. The aim of this study was to profile DQB1 alleles in a Chinese population and to identify specific DQB1 alleles in association with SSc of Han Chinese. A cohort containing 213 patients with SSc and 239 gender-matched and unrelated controls was examined in the study. The HLA-DQB1 genotyping was performed with sequence-based typing (SBT) method. Exact p-values were obtained (Fisher's test) from 2x2 tables of allele counts or allele carriers and disease status. Seventeen DQB1 alleles were found in the cohort. DQB1*03:03 was the most common allele in this cohort. DQB1*05:01 was significantly increased in SSc, and was strongly associated with anti-centromere autoantibodies (ACA). Compared with SSc in other ethnic populations, SSc patients of Han Chinese are distinct in association with DQB1*06:11, common in association with DQB1*05:01, but lack association with DQB1*03:01. In addition, DQB1*06:01 appeared more common in ATA-positive Chinese SSc, and marginally associated with pulmonary fibrosis, and an increased frequency of DQB1*03:03 was observed in anti-U1RNP-positive Chinese SSc patients. FAU - Zhou, X D AU - Zhou XD AD - Division of Rheumatology and Clinical Immunogenetics, University of Texas Medical School, Houston, USA. FAU - Yi, L AU - Yi L FAU - Guo, X J AU - Guo XJ FAU - Chen, E AU - Chen E FAU - Zou, H J AU - Zou HJ FAU - Jin, L AU - Jin L FAU - Mayes, M D AU - Mayes MD FAU - Assassi, S AU - Assassi S FAU - Wang, J C AU - Wang JC LA - eng GR - P50 AR054144/AR/NIAMS NIH HHS/United States GR - R01 AR055258/AR/NIAMS NIH HHS/United States GR - U01 AI090909/AI/NIAID NIH HHS/United States GR - 1U01AI09090/AI/NIAID NIH HHS/United States PT - Letter PT - Multicenter Study PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - England TA - Int J Immunopathol Pharmacol JT - International journal of immunopathology and pharmacology JID - 8911335 RN - 0 (Antibodies, Antinuclear) RN - 0 (Biomarkers) RN - 0 (HLA-DQ beta-Chains) RN - 0 (HLA-DQB1 antigen) RN - 0 (anticentromere antibody) SB - IM MH - Antibodies, Antinuclear/blood MH - Asian People/*genetics MH - Biomarkers/blood MH - Case-Control Studies MH - China/epidemiology MH - Female MH - Gene Frequency MH - Genetic Predisposition to Disease MH - HLA-DQ beta-Chains/*genetics MH - Humans MH - Male MH - Odds Ratio MH - Phenotype MH - Pulmonary Fibrosis/blood/ethnology/genetics/immunology MH - Risk Factors MH - Scleroderma, Systemic/blood/ethnology/*genetics/immunology PMC - PMC3887513 MID - NIHMS543413 COIS- DISCLOSURE: ALL AUTHORS REPORT NO CONFLICTS OF INTEREST RELEVANT TO THIS ARTICLE. EDAT- 2013/09/27 06:00 MHDA- 2014/03/29 06:00 PMCR- 2014/07/01 CRDT- 2013/09/27 06:00 PHST- 2013/09/27 06:00 [entrez] PHST- 2013/09/27 06:00 [pubmed] PHST- 2014/03/29 06:00 [medline] PHST- 2014/07/01 00:00 [pmc-release] AID - 18 [pii] AID - 10.1177/039463201302600318 [doi] PST - ppublish SO - Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):747-51. doi: 10.1177/039463201302600318.